MAP2K7 and neoplasm: The MEK/ERK/c‐Myc noncanonical pathway is also crucial in regulating the metastatic ability of tumor cells.[47] In addition, c‐Myc regulates the G1/S transition of the cell cycle through the cyclin‐dependent kinases (cyclin‐CDK) complex and plays important roles in tumor proliferation.